Skip to main content

Elisabet Miro Casas

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Elisabet Miro Casas

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Inhibición del intercambiador sodio/calcio mitocondrial, NCLX, como estrategia para reducir el daño por isquemia-reperfusión durante un infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Elisabet Miro Casas, Gino Freddy Sena Ganse
Funding agency: FUNDACIÓN ESPAÑOLA DE ARTERIOSCLEROSIS
Funding: 15000
Reference: FEA/RODRIGUEZ/2024
Duration: 01/01/2025 - 31/12/2027

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Elisabet Miro Casas, Marisol Ruiz Meana, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Fundación Eugenio Rodríguez Pascual
Funding: 25000
Reference: FERP/2024/RODRIGUEZ
Duration: 15/01/2025 - 14/01/2027

Role of amino acid metabolism reprogramming and calpain deregulation in fibroblasts activation and diffuse myocardial fibrosis in heart failure

IP: Javier Inserte Igual
Collaborators: José Antonio Barrabés Riu, David Aluja Gonzalez, Juan Garrido Oliver, Elisabet Miro Casas, Sara Delgado Tomás
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI23/00068
Duration: 01/01/2024 - 31/12/2027

Daño mitocondrial por estrés dicarbonílico como impulsor de la senescencia: papel de los senolíticos en la protección del corazón durante el envejecimiento.

IP: Marisol Ruiz Meana
Collaborators: Rafael Rodríguez Lecoq, David Aluja Gonzalez, Elisabet Miro Casas
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI22/00513
Duration: 01/01/2023 - 31/12/2026

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Cendy Gabriela Laínez Laínez

Cendy Gabriela Laínez Laínez

Research technician
Epidemiology and Public Health
Read more
Eva Vila Escude

Eva Vila Escude

Research technician
Biomedical Research in Gynaecology
Read more
Laura Salamó Palau

Laura Salamó Palau

Predoctoral researcher
Biomedical Research in Gynaecology
Read more
Eva Maía Pastor Arroyo

Eva Maía Pastor Arroyo

Research technician
Kidney Physiopathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.